Cite

HARVARD Citation

    Benedict, R. et al. (2018). Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study. Multiple sclerosis. pp. 795-804. [Online]. 
  
Back to record